(Q39471938)

12 September 2017

title

CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo (English)

1 reference

12 September 2017

Philip G Stevenson

7

0 references

Gabrielle Belz

object named as

Gabrielle T Belz

6

0 references

author name string

Christopher M Smith

1

1 reference

12 September 2017

Gustavo T L Rosa

2

1 reference

12 September 2017

Janet S May

3

1 reference

12 September 2017

Neil J Bennett

4

1 reference

12 September 2017

Adele M Mount

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

European Journal of Immunology

12 September 2017

published in

1 reference

12 September 2017

volume

36

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

3186-3197

1 reference

Immunological control of a murine gammaherpesvirus independent of CD8+ T cells

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Immune mechanisms in murine gammaherpesvirus-68 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Gamma-herpesvirus latency requires T cell evasion during episome maintenance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Interactions of the murine gammaherpesvirus with the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Immune evasion by gamma-herpesviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

MHC class I ubiquitination by a viral PHD/LAP finger protein.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Virus subversion of the MHC class I peptide-loading complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Viral degradation of the MHC class I peptide loading complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Lymphocyte-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636164

7 January 2021

Identifiers

DOI

10.1002/EJI.200636164

1 reference

12 September 2017

1 reference